Rapid high performance liquid chromatographic determination of risperidone in human plasma

Iranian Journal of Pharmaceutical Research

Volumn 5, Issue 1, 2006, Pages 37-40

  Foroutan, Seyyed Mohsen ^a   Zarghi, Afshin ^a   Shafaati, Alireza ^a   Khoddam, Arash ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Noor Research and Educational Institute   (Iran)

Author keywords

HPLC; Plasma; Risperidone

Indexed keywords

EID: 84875141615     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/IJPR.2010.650     Document Type: Article

References (11)

1. Robinson RC. Risperidone hydrochloride-new anxiolytic agent. Drugs Today (1987) 23: 311-318
2. Dommisse CS and De Vane CL. Risperidone: new type of anxiolytic drug. Intell. Clin. Pharm. (1985) 19: 624-628
3. Odou P, Levron J C, Luyckx M, Brunet C and Robert H. Risperidone drug monitoring: useful clinical tool? Clin. Drug Invest. (2000) 19: 283-292
4. Remmerie BMM, Sips LLA, de Vries R, de Jong J, Schothuis AM, Hooijschuur EWJ and van de Merbel NC. Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B (2003) 783: 461- 472
5. Flarakos J, Luo W, Aman M, Svinarov D, Gerber N and Vouros P. Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry. J. Chromatogr. A (2004) 1026: 175-181
6. Aravagiri M, Marder SR, Van Putten T and Midha KK. Determination of risperidone in plasma by high performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients. J. Pharm. Sci. (1993) 82: 447-449
7. Price MC and Hoffman DW. Therapeutic drug monitoring of risperidone and 9-hydroxyrisperidone in serum with solid-phase extraction and highperformance liquid chromatography. Ther. Drug Monit. (1997) 19: 333-337
8. Nagasaki T, Ohkub T, Sugawara K, Yasui N, Furukori H and Kaneko S. Determination of risperidone and 9-hydroxyrisperidone in human plasma by highperformance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia. J. Pharm. Biomed. Anal. (1999) 19: 595-601
9. Avenoso A, Facciola G, Salemi M and Spina E. Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversedphase liquid chromatography with ultraviolet detection. J. Chromatogr. B, Biomed. Apl. (2000) 746: 173-181
10. Titier K, Deridet E, Cardone E, Abouelfath A and Moore N. Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose. J. Chromatogr. B (2002) 772: 373-378
11. Guierrez R, Lee PI, Huang ML and Woestenborghs R. Risperidone: effects of formulations on oral bioavailability. Pharmacother. (1997) 17: 599-605